{
    "nctId": "NCT00107484",
    "briefTitle": "Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer",
    "officialTitle": "Phase II Study of Combidex in Axillary Node Staging in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 3,
    "primaryOutcomeMeasure": "Utility of magnetic resonance imaging using ferumoxtran-10 in identifying metastases to axillary lymph nodes",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically or cytologically confirmed invasive breast cancer\n* Candidate for sentinel lymph node biopsy and/or axillary lymph node dissection\n* Hormone receptor status:\n\n  * Not specified\n\nPATIENT CHARACTERISTICS:\n\nAge\n\n* 18 and over\n\nSex\n\n* Male or female\n\nMenopausal status\n\n* Not specified\n\nPerformance status\n\n* Not specified\n\nLife expectancy\n\n* Not specified\n\nHematopoietic\n\n* WBC \u2265 3,000/mm\\^3\n* Absolute neutrophil count \u2265 1,500/mm\\^3\n* Platelet count \\> 100,000/mm\\^3\n* Ferritin \u2264 350 ng/mL\\*\n* Transferrin saturation level \u2264 40%\\* NOTE: \\*Patients with lab values above these limits may be eligible provided there is no hemochromatosis by hematology consultation\n\nHepatic\n\n* Bilirubin normal\n* AST and ALT \u2264 2.5 times upper limit of normal\n* Alkaline phosphatase normal\n* PT normal\n* Albumin normal\n* No history of cirrhosis\n\nRenal\n\n* Creatinine normal OR\n* Creatinine clearance \\> 60 mL/min\n\nCardiovascular\n\n* No symptomatic congestive heart failure\n* No unstable angina pectoris\n* No cardiac arrhythmia\n\nOther\n\n* Not pregnant or nursing\n* Negative pregnancy test\n* Medically stable\n* No ongoing or active infection\n* No history of allergic reaction attributed to compounds of similar chemical or biological composition to ferumoxtran-10 (e.g., iron preparations, parenteral iron, parenteral dextran, parenteral iron-dextran, or parenteral iron-polysaccharide preparations)\n* No history of allergic reaction to any contrast media\n* No immunodeficiency that would predispose patient to a specific or non-specific mediator release\n* No contraindication to MRI, including any of the following:\n\n  * Severe claustrophobia\n  * Pacemaker\n  * Aneurysm clips\n  * Defibrillators\n  * Certain types of replacement joints\n  * Other institutional contraindication to MRI\n* No psychiatric illness or social situation that would preclude study compliance\n* No other uncontrolled illness\n\nPRIOR CONCURRENT THERAPY:\n\nBiologic therapy\n\n* Not specified\n\nChemotherapy\n\n* Not specified\n\nEndocrine therapy\n\n* Not specified\n\nRadiotherapy\n\n* Not specified\n\nSurgery\n\n* Not specified\n\nOther\n\n* More than 30 days since prior investigational agents\n* More than 3 months since prior ferumoxides",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}